Efficacy of mesalazine in IBS

Affiliations

¹ Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.

Free article

Comment

Thazin Min et al. Gut. 2016 Jan.

Free article

. 2016 Jan;65(1):187-8.

doi: 10.1136/gutjnl-2015-309593. Epub 2015 Apr 14.

¹ Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.

No abstract available

Keywords: IRRITABLE BOWEL SYNDROME.

Comment on

Randomised controlled trial of mesalazine in IBS.
Barbara G, Cremon C, Annese V, Basilisco G, Bazzoli F, Bellini M, Benedetti A, Benini L, Bossa F, Buldrini P, Cicala M, Cuomo R, Germanà B, Molteni P, Neri M, Rodi M, Saggioro A, Scribano ML, Vecchi M, Zoli G, Corinaldesi R, Stanghellini V. Barbara G, et al. Gut. 2016 Jan;65(1):82-90. doi: 10.1136/gutjnl-2014-308188. Epub 2014 Dec 22. Gut. 2016. PMID: 25533646 Free PMC article. Clinical Trial.
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).
Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF, Zaitoun A, Montgomery A, Spiller R. Lam C, et al. Gut. 2016 Jan;65(1):91-9. doi: 10.1136/gutjnl-2015-309122. Epub 2015 Mar 12. Gut. 2016. PMID: 25765462 Free PMC article. Clinical Trial.